Arguello-Tomas, M, Albiol, N, Moreno, C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; 147(1)DOI:10.1159/000534730. PMID:37899041. IF:1.700(Q3/8D).

Socié G., Barba P., Barlev A., Sanz J., García-Cadenas I., Chevallier P., Fagioli F., Guzman-Becerra N., Kumar D., Ljungman P., Pigneux A., Sadetsky N., Yáñez San Segundo L., Shadman M., Storek J., Thirumalai D., Xing B., Mohty M.. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; 59(1)DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4.500(Q1/2D).

Piñana, JL, Heras, I, Aiello, TF, García-Cadenas, I, Vazquez, L, Lopez-Jimenez, J, Chorao, P, Aroca, C, García-Vidal, C, Arroyo, I, Soler-Espejo, E, López-Corral, L, Avendaño-Pita, A, Arrufat, A, Garcia-Gutierrez, V, Arellano, E, Hernández-Medina, L, González-Santillana, C, Morell, J, Hernández-Rivas, JA, Rodriguez-Galvez, P, Mico-Cerdá, M, Guerreiro, M, Campos, D, Navarro, D, Cedillo, A, Martino, R, Solano, C. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses-Basel. 2023; 15(10)DOI:10.3390/v15102066. PMID:37896843. IF:3.800(Q2/5D).

Albiol, N, Lynton-Pons, E, Aso, O, Moga, E, Vidal, S, Gomez-Perez, L, Santiago, JA, Triquell, M, Roch, N, Lazaro, E, Gonzalez, I, Lopez-Contreras, J, Esquirol, A, Sierra, J, Martino, R, Garcia-Cadenas, I. mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. LEUKEMIA RESEARCH. 2023; 132DOI:10.1016/j.leukres.2023.107347. PMID:37356281. IF:2.100(Q3/6D).